These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12125069)

  • 1. Ill-fated amyloid-beta vaccine.
    Smith MA; Atwood CS; Joseph JA; Perry G
    J Neurosci Res; 2002 Aug; 69(3):285. PubMed ID: 12125069
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxicity of beta-amyloid vaccination in patients with Alzheimer's disease.
    Imbimbo BP
    Ann Neurol; 2002 Jun; 51(6):794. PubMed ID: 12112091
    [No Abstract]   [Full Text] [Related]  

  • 3. Set back to Alzheimer vaccine studies.
    Birmingham K; Frantz S
    Nat Med; 2002 Mar; 8(3):199-200. PubMed ID: 11875473
    [No Abstract]   [Full Text] [Related]  

  • 4. New hope for Alzheimer disease vaccine.
    Haass C
    Nat Med; 2002 Nov; 8(11):1195-6. PubMed ID: 12411936
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vaccines for Alzheimer's disease?].
    Nau JY
    Rev Med Suisse; 2005 Jul; 1(27):1819. PubMed ID: 16119300
    [No Abstract]   [Full Text] [Related]  

  • 7. Dangers of the amyloid-beta vaccination.
    Smith MA; Joseph JA; Atwood CS; Perry G
    Acta Neuropathol; 2002 Jul; 104(1):110. PubMed ID: 12070672
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccine for Alzheimer's disease?
    Health News; 2006 Oct; 12(10):2. PubMed ID: 17162790
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
    Matsuda J; Kaminaka K; Nozaki C
    Biochem Biophys Res Commun; 2009 Apr; 382(1):149-52. PubMed ID: 19265678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-beta: a vascular sealant that protects against hemorrhage?
    Atwood CS; Bishop GM; Perry G; Smith MA
    J Neurosci Res; 2002 Nov; 70(3):356. PubMed ID: 12391596
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer disease's double-edged vaccine.
    Greenberg SM; Bacskai BJ; Hyman BT
    Nat Med; 2003 Apr; 9(4):389-90. PubMed ID: 12640449
    [No Abstract]   [Full Text] [Related]  

  • 12. Toward modeling hemorrhagic and encephalitic complications of Alzheimer amyloid-beta vaccination in nonhuman primates.
    Gandy S; Walker L
    Curr Opin Immunol; 2004 Oct; 16(5):607-15. PubMed ID: 15342007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insoluble problem?
    Nat Med; 2002 Mar; 8(3):191. PubMed ID: 11875465
    [No Abstract]   [Full Text] [Related]  

  • 14. Designer vaccine for Alzheimer's?
    Doherty M
    Drug Discov Today; 2004 Sep; 9(17):730-1. PubMed ID: 15450233
    [No Abstract]   [Full Text] [Related]  

  • 15. Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease.
    Masliah E; Hansen L; Adame A; Crews L; Bard F; Lee C; Seubert P; Games D; Kirby L; Schenk D
    Neurology; 2005 Jan; 64(1):129-31. PubMed ID: 15642916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current progress in beta-amyloid immunotherapy.
    Schenk D; Hagen M; Seubert P
    Curr Opin Immunol; 2004 Oct; 16(5):599-606. PubMed ID: 15342006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's vaccine: a cure as dangerous as the disease?
    Münch G; Robinson SR
    J Neural Transm (Vienna); 2002 Apr; 109(4):537-9. PubMed ID: 11956972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 12th international conference on Alzheimer's disease. Part 2. 11-16 July 2009, Vienna, Austria.
    Filson S
    IDrugs; 2009 Sep; 12(9):537-8. PubMed ID: 19697268
    [No Abstract]   [Full Text] [Related]  

  • 19. Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.
    Muhs A; Hickman DT; Pihlgren M; Chuard N; Giriens V; Meerschman C; van der Auwera I; van Leuven F; Sugawara M; Weingertner MC; Bechinger B; Greferath R; Kolonko N; Nagel-Steger L; Riesner D; Brady RO; Pfeifer A; Nicolau C
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9810-5. PubMed ID: 17517595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.
    Tong XK; Nicolakakis N; Fernandes P; Ongali B; Brouillette J; Quirion R; Hamel E
    Neurobiol Dis; 2009 Sep; 35(3):406-14. PubMed ID: 19524673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.